期刊文献+

咪喹莫特对致敏大鼠支气管旁淋巴结T辅助淋巴细胞亚群产生细胞因子的影响 被引量:1

Modulation of T-lymphocyte subsets production with imiquimod in the PBLN cell cultures from ovalbumin-sensitized rats
原文传递
导出
摘要 目的研究免疫调节剂咪喹莫特对卵蛋白(OVA)致敏大鼠支气管旁淋巴结(PBLN)细胞培养体系中T辅助淋巴细胞(Th)亚群产生细胞因子的影响,并探讨其作用机制。方法建立PBLN细胞培养体系,并按不同浓度分为A~F组进行干预。在培养0、3、6、12、24、48h后,各组分别取5孔细胞培养液,用酶联免疫吸附法(ELISA)检测各细胞因子的蛋白质水平,用逆转录聚合酶链反应(RTPCR)检测细胞沉淀中白细胞介素(IL)4和干扰素(IFN)γ等细胞因子的mRNA表达。结果在A组的各时间点PBLN细胞培养液中,仅可检测到少量IFNγ。随着培养时间的延长,咪喹莫特浓度为1、10μg/ml的E和F组与B组相比,IL4及相关mRNA水平增加缓慢,IFNγ水平增长迅速(均P<0.005)。此作用从培养6h开始,12h达峰值,持续至24h。在培养12~48h时,C组IL4表达与B组比,差异有统计学意义(P<0.05),而IFNγ表达无差异(P>0.05)。结论咪喹莫特对致敏大鼠PBLN细胞培养体系中Th亚群产生细胞因子的最佳作用发生在12h时,提示咪喹莫特可能在支气管哮喘等特异性疾病的迟发炎症反应阶段发挥重要作用。 Objective To observe the effect and mechanism of imiquimod on T helper (Th) cell subsets in the Parabronchial lymph node (PBLN) cell cultures from ovalbumin (OVA)-sensitized rats. Methods PBLN were isolated and cultured. PBLN cells were divided into A ~ F, according to different concentrations of intervention. Cultured for 0, 3, 6, 12, 24, 48 hours, the expressions of IL-4 and IFN-γ in supernatants were determined by ELISA. The mRNA expressions of the cytokines in cells weredetected by RT-PCR. Results In the group A, only low concentrations of IFN-γ were detected. Based on the cultured time, the concentrations of IFN-γ were increased significantly if imiquimod concentration was between 1 and 10 μg/ml. Levels of IL-4 were increased slowly compared with those in the group B (P 〈0. 005). The effect began at 6h, achieved peak at 12 h, continued 24 h. Between 12 h and 48 h, significant differences of IL-4 levels were found in the group C. The levels of IFN-γ in the group C were found no difference compared with those in group B ( P 〉 0. 05 ). Conclusion Imiquimod show the best effect on antigen-specific Th cell subsets when cultured for 12h. The results suggest that imiquimod have benefit in atopic diseases such as the late inflammation reaction of asthma.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2005年第8期844-846,共3页 Chinese Journal of Laboratory Medicine
基金 江苏省科委国际合作项目资助课题(BZ2001053)
  • 相关文献

参考文献7

  • 1Dockrell DH, Kinghorn GR. Imiquimod and resiquimod as novel immunomodulators. J Antimicrobial Chemother, 2001,48:751- 755.
  • 2Tyring S, Conant M, Marini M, et al. lmiquimod:an international update on therapeutic uses in dermatology.Int J Dermatol, 2002,41:810- 816.
  • 3吴巧珍,殷凯生,王祥.咪喹莫特对支气管哮喘大鼠辅助性T淋巴细胞亚群的作用[J].中华结核和呼吸杂志,2004,27(5):355-357. 被引量:26
  • 4Van Oosterhout A J, HofsWa CL, Shields R, et al. Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murlne model of allergic asthma.Am J Respir Cell Mol Biol. 1997.17:386-392.
  • 5Gupta AK, Browne M, Bluhm R. Imiquimod:a review. J Cutan Med Surg, 2002,6:554-560.
  • 6Stokes JR, Sorkness RL, Kaplan MR, et al. Attenuation of virus-induced airway dysfunction in rats treated with imiquimod. Eur Respir J, 1998 ,11:324-329.
  • 7Wagner TL, Ahonen CL, Conture AM, et al. Modulation of TH1 and TH2 cytokine production with the immune response modifiers,R-848 and imiquimod. Cell Immunol, 1999,191:10-19.

二级参考文献3

  • 1Huang TJ, MacAry PA, Eynott P, et al. Allergen-specific Th1 cells counteract efferent Th2 cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-gamma. J Immunol, 2001, 166:207-217.
  • 2Cohn L, Homer RJ, Niu N, et al. T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production. J Exp Med, 1999, 190: 1309-1318.
  • 3Wagner TL, Ahonen CL, Conture AM, et al. Modulation of Th1 and Th2 cytokine production with the immune response modifiers, R-848 and imiquimod. Cell Immunol, 1999, 191: 10-19.

共引文献25

同被引文献11

  • 1Umetsu DT, McIntire JJ, Akbari O, et al. Asthma: an epidemic of dysregulated immunity. Nat Immunol, 2002, 3(8) : 715-720.
  • 2Braford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976, 72(7) : 248-254.
  • 3Szabo S J, Sullivan BM, Peng SL, et al. Molecular mechanisms regulating Thl immune responses. Nat Rev Immunol, 2003, 21 : 713-758.
  • 4Ansel KM, Lee DU, Rao A. An epigenetic view of helper T cell differentiation. Nat Immunol, 2003, 4(7): 616-623.
  • 5Tonnel AB, Capron M. Recent data on the physiopathology of respiratory allergies. Bull Acad Natl Med, 1997, 181 (8): 1563- 1574.
  • 6Szabo SJ, Kim ST, Costa GL, et al. A novel transcription factor, T-bet, directs Thl lineage commitment. Cell, 2000, 100 ( 17 ) : 655 -669.
  • 7Lighvani AA, Frucht DM, Jankovic D, et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci USA, 2001, 98(26) : 15137-15142.
  • 8Zheng W, Flavell RA. Transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene in CD4^+ T cells. Cell, 1997, 89(4) : 587-596.
  • 9Lee HJ, Tskemoto N, Kurata H, et al. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Thl cells. J Exp Med, 2000, 192(1) : 105-115.
  • 10Gupta AK, Browne M, Bluhm R. Imiquimod: a review. J Cutan Med Surg, 2002, 6(6) : 554-560.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部